- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03084458
Does Activity Feedback Increase ICD Patient Activity Levels?
Medical device technology for use by patients is gaining popularity. Modern cardiac disease management seeks to integrate multiple device technologies and capabilities to optimize health outcomes. Fitbit, Inc. manufactures a line of wireless-enabled activity, wearable trackers that are used in conjunction with a mobile device. The Fitbit trackers use three-dimensional accelerometers to sense and record movement. This technology represents a new frontier for patients and their health care providers to understand and track physical activity in real time. The primary aim of the current project is to assess whether activity feedback using FitBit technology affects implantable cardioverter defibrillator (ICD) patient activity level as measured by the ICD accelerometer. The investigators will also examine the perceived added value of Fitbit technology to an ICD patient user experience.
Approximately 50 participants will be recruited. Participants in the experimental group (n = 25) will use the Fitbit device for 12 weeks. The experimental group will receive fitness goals (number of steps per day) to increase activity from a baseline value to a minimum of 7000 steps per day by week 9 of the intervention. Both groups will receive weekly texts messages to encourage activity. Feedback about technology satisfaction, cardiac anxiety, cardiac self-care, and health care utilization will be elicited from patients at multiple time points. Additional information will be gained about patient decision-making as participants may elect to continue Fitbit use beyond the study period; this will allow for behavioral evidence of the perceived value of adding this technology.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina - Chapel Hill
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- has a Medtronic ICD
- access to a smartphone, tablet, or computer with internet access
- English speaking
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Once consented, recruited ICD patients will complete the baseline psychosocial and quality of life measures.
At the first and final visit, a 6-minute walk test will be administered.
Participants will be sent text messages to encourage physical activity.
Participants will be re-assessed with psychosocial and quality of life measures at 30 and 90 days post enrollment.
At the final (90 day) visit participants ICD will be interrogated to obtain accelerometer activity data.
|
|
Experimental: Fitbit
Same as control condition.
In addition, participants in the experimental group will receive a Fitbit device with full instructions and troubleshooting.
These participants will be given daily step goals, which will be increased during the course of the study, and be able to monitor their progress using the Fitbit app.
|
The Fitbit device will allow experimental group participant access to their daily step count.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Does increased access to information on daily activity level (FitBit) increase device (ICD) coded total activity (step count) over usual care?
Time Frame: 12 weeks
|
At the final study visit, the ICD will be interrogated. Accelerometer data will be captured and used as a precise measure of physical activity, specifically, steps per day. Analyses will be conducted to determine activity (step count) changes between groups and over time. |
12 weeks
|
Does activity level feedback have a greater impact on Quality of Life (QOL) than usual care? Indices of QOL will be multiple questionnaire scores entered together in a single analysis.
Time Frame: 12 weeks
|
Questionnaires that will be used include: Cardiac Anxiety Questionnaire, Duke Activity Status Index, Fitbit Technology Satisfaction, Florida Patient Acceptance Survey, Florida Shock Anxiety Scale, Patient Health Security, Self-Care of Heart Failure Index, and the Short-Form 12 Health Survey.
Analyses will be conducted to determine quality of life changes between groups and over time from the baseline, month 1, and month 3 visits.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ashley Burch, East Carolina Univerity
- Principal Investigator: Samuel Sears, East Carolina Univerity
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CR3535
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ICD Patients
-
Biotronik, Inc.CompletedPatients Indicated for an ICDUnited States
-
Guidant CorporationCompleted
-
Meir Hospital, Kfar Saba, IsraelUnknown
-
Englewood Hospital and Medical CenterMedtronicCompletedUtility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillatorsPatients With a Generation 2 Medtronic Implantable Cardioverter-defibrillator(ICD)United States
-
Medtronic Bakken Research CenterMedtronic GmbH GermanyCompletedPatients With an Indication for an ICD Implantation According to the Guidelines
-
Eli Sprecher, MDRecruitingPatients With an Implanted S-ICD Who Continue to Exercise RegularlyIsrael
-
University Hospital Inselspital, BerneTerminatedHeart Patients After ICD ImplantationSwitzerland
-
Universitätsklinikum KölnUniversity Hospital Southampton NHS Foundation Trust; Uniklinik Ulm; St.Barts... and other collaboratorsCompleted
-
Policlinico Casilino ASL RMBWithdrawnHeart Rate Control in ICD Patients With Heart FailureItaly
-
University Hospital, SaarlandFriede Springer Herz StiftungCompletedHeart Failure Patients Before and After ICD ImplantationGermany
Clinical Trials on Fitbit
-
Ohio State UniversityNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedCardiovascular Diseases | Physical Activity | Kidney Transplant; Complications | Cardiorenal; ChangeUnited States
-
The London Spine CentreUnknownLumbar Degenerative Spinal StenosisCanada
-
University of South CarolinaCompletedArthroplasty, Replacement, KneeUnited States
-
Mayo ClinicCompleted
-
Seattle Children's HospitalCompleted
-
University of IowaNational Heart, Lung, and Blood Institute (NHLBI)CompletedSedentary Lifestyle
-
Dana-Farber Cancer InstituteCompleted
-
University of VermontUnknown
-
California Polytechnic State University-San Luis...CompletedCancer | Physical Activity | IncentivesUnited States